Importantly, targeting STAT3 in the immune system might have complex systemic effects ranging from autoimmunity to immunodeficiency as indicated by phenotypes of patients with mutations in STAT3 (112–116). This evidence concerns the gene STAT3 and immunodeficiency disease.